Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients

AimThe pathophysiology of insulin resistance (IR) comprises a complex adipokine mediated cross-talk between white adipose tissue and other organs. Dipeptidyl peptidase-4 (DPP4) is protease recently proposed as a novel adipokine linked to IR. We aimed to assess the relationship between fasting serum DPP4 activityand IR in type 1 diabetic (T1DM) patients.MethodsA cross-sectional study comprised 44 T1DM patients aged > 18 and < 65 years. IR was esimated using the equation for insulin sensitivity derived from euglycemic-hyperinsulinemic clamp studies-estimated glucose disposal rate (eGDR). DPP4 serum activity was determined spectrophotometrically as a rate of cleavage of 7-Amino-4-Methyl Coumarin (AMC) from H-Gly-Pro-AMC.ResultsPatients were divided according to DPP4 activity tertiles (< 25.40; ≥ 36.54 U/L). Fasting serum DPP4 activity was related to disease duration (p = 0.012), systolic (p = 0.009) and diastolic (p = 0.047) blood pressure, waist circumference (p = 0.037), urine albumin excretion (p = 0.022) and conversely related to eGDR (p = 0.004). The linear regression has shown that eGDR decreases for 0.203 mg kg− 1 min− 1 by each increase of serum DPP4 activity of 1 U/L (p < 0.001) after adjustment for adjusted for age, gender, disease duration, albuminuria and the use of antihypertensives and statins.ConclusionSerum DPP4 activity is associated with IR in T1DM patients and it might play an important role in its pathophysiology.